Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis.

Visomitin (plastoquinonyl decyl triphenylphosphonium) - Mitotech, BIO invest

http://www.ncbi.nlm.nih.gov/pubmed/40698330

Bin Pan; Haoming Wang; Haotian Yang; Hong Xue; Hongpu Song; Hongwei Xie; Huali Ye; Peihua Shi; Putao Yuan; Xuewu Sun; Ying Liu; Zhenhua Feng; Ziang Xie; Zihan Dai

Jul 23, 2025